94 related articles for article (PubMed ID: 1936483)
1. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
Klein W
Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
[TBL] [Abstract][Full Text] [Related]
2. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Umpierrez G; Issa M; Vlajnic A
Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
5. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
Drzewoski J; Czupryniak L
Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
8. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly).
Lalau JD; Vermersch A; Hary L; Andrejak M; Isnard F; Quichaud J
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):329-32. PubMed ID: 2272714
[TBL] [Abstract][Full Text] [Related]
11. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
[TBL] [Abstract][Full Text] [Related]
12. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
13. Management of type 2 diabetes mellitus with special reference to metformin therapy.
Campbell IW
Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
[TBL] [Abstract][Full Text] [Related]
14. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of the secondary failure of sulfonylurea therapy].
Sauer H
Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
[No Abstract] [Full Text] [Related]
16. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
Vigneri R; Trischitta V; Italia S; Mazzarino S; Rabuazzo MA; Squatrito S
Diabete Metab; 1991 May; 17(1 Pt 2):232-4. PubMed ID: 1936482
[TBL] [Abstract][Full Text] [Related]
17. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
Wilson JA; Scott MM; Gray RS
Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Groop L; Widén E
Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes.
Teupe B; Bergis K
Diabete Metab; 1991 May; 17(1 Pt 2):213-7. PubMed ID: 1936479
[TBL] [Abstract][Full Text] [Related]
20. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
Aguilar CA; Wong B; Gómez-Pérez FJ; Rull JA
Rev Invest Clin; 1992; 44(1):71-6. PubMed ID: 1523352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
